LEADER 01460nam  2200421   450 
001 9910715098403321
005 20221025171423.0
035   $a(CKB)4100000011919936
035   $a(NjHacI)994100000011919936
035   $a(OCoLC)1148207539
035   $a(EXLCZ)994100000011919936
100   $a20221025d2019      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aAromatherapy and essential oils $ea map of the evidence /$fMichele Freeman [and three others]
210  1$aWashington (DC) :$cDepartment of Veterans Affairs (US),$d[2019]
210  4$dİ2019
215   $a1 online resource (v, 58 pages) $cillustrations
225 1 $aEvidence-based synthesis program
300   $a"September 2019."
320   $aIncludes bibliographical references.
410  0$aEvidence-based synthesis program (Series)
517   $aAromatherapy and essential oils 
606   $aAromatherapy
615  0$aAromatherapy.
676   $a615.321
700   $aFreeman$b Michele$01353979
712 02$aUnited States.$bDepartment of Veterans Affairs.$bHealth Services Research and Development Service,
712 02$aPortland VA Medical Center.$bEvidence-based Synthesis Program Center.
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910715098403321
996   $aAromatherapy and essential oils$93291176
997   $aUNINA